Freenome

Our Chief Scientific Officer, Jimmy Lin, shares results about our multiomics blood test's ability to detect pre-cancerous colorectal advanced adenomas tomorrow at the ASCO-GI Symposium. Importantly, the data shows that our multiomics approach detected twice as many advanced adenomas as cell-free DNA methylation-only or single-protein approaches. > Read more at:https://www.freenome.com/blood-based-detection-of-advanced- > ASCO-GI participants can view his presentation at:https://meetinglibrary.asco.org/record/194102/video

Emerging Innovation in Colorectal Cancer Screening with a Routine Blood Draw Cancer Guardian members recognize the importance of detecting cancer early, when it... is preventable and most treatable. Did you know that colorectal cancer is the second deadliest cancer in the U.S. and among the most preventable and treatable when detected early? If you are between the ages of 45 and 85, we ask you to consider the American Cancer Society Guideline for Colorectal Cancer Screening and schedule your colon cancer screening. We also want to share some promising trends in making CRC screening accessible and encourage our members to remain current with their CRC screening. As part of initiatives to adapt to the COVID-19 pandemic, the PREEMPT CRC registrational clinical trial has expanded access to enroll patients from anywhere in the U.S., except Hawaii, and is intended to validate a blood test that can provide an accurate, convenient, and patient-friendly option to be screened for colorectal cancer. All eligible 45-to 85-year old patients can participate in the clinical study. Contribute to the fight against CRC! Enroll in the Study www.science37.com/participants/oncology/preemptcrc/

ABC story highlights disparities in #coloncancer rates. "Colon cancer may not display any symptoms at all, which is why experts stress the importance of screenings. https://goodmorningamerica.com//chadwick-bosemans-death-pu Learn about the PREEMPT CRC clinical trial: http://bit.ly/FNPREEMPTCRC

Colon cancer is one of the most common cancers in the United StatesDo not avoid preventive healthcare screenings or tests. https://vitals.lifehacker.com/what-you-should-know-about-co Consider the PREEMPT-CRC clinical trial http://preemptcrc.com #coloncancer

Dr. Dana Hayden in IL: We know that the numbers are going up in younger people, but it’s still much more common to get colorectal cancer over 50. #coloncancer screening. https://chicagotribune.com//ct-life-chadwick-boseman-colon Learn about the PREEMPT CRC clinical trial: http://bit.ly/FNPREEMPTCRC

Chadwick Boseman's death puts spotlight on colon cancer among Black men, young people https://www.goodmorningamerica.com//chadwick-bosemans-deat Learn about the PREEMPT CRC clinical trial: http://bit.ly/FNPREEMPTCRC #coloncancer #cancerscreening

Please don't delay scheduling your #coloncancer screening. COVID-19 has reduced #cancerscreenings by 60-80% since March, but now is the time to resume your screening. How the COVID-19 Pandemic Has Changed Cancer Care. Consider helping with new screening options. Together we can prevent CRC. PREEMPT CRC clinical trial: preemptcrc.com https://time.com/5884236/coronavirus-pandemic-cancer-care/

Screening tests make #coloncancer preventable and treatable. Consider PREEMPT-CRC clinical trial for #ColorectalCancer screening. #coloncancerawareness #cancerscreening https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977418/ preemptcrc.com

Check out Gabe's interview with the Center for Data Innovation, where he talks about the future of machine learning-based diagnostics. https://www.datainnovation.org//5-qs-for-gabe-otte-ceo-of/

STAT Boseman’s death is reinvigorating discussions about the rising incidence of colon cancer in young people, meaning those under age 50, as well as about racial inequities in colon cancer screening Together we can prevent #coloncancer www.preemptcrc.com https://www.statnews.com//disparities-kill-king-of-wakanda #cancerawareness

After #ChadwickBoseman’s death from colon cancer, many people have questions about this disease. Screening tests make colon cancer preventable and treatable. Consider PREEMPT-CRC clinical trial for #coloncancer screening. See expert advice in #NYT. https://www.nytimes.com//colon-cancer-chadwick-boseman.html PREEMPTCRC.COM

Don't delay scheduling your #coloncancer screening! PREEMPT CRC Trial for Blood-based Test to Detect Colon Cancer Has Expanded to Enroll Patients from Anywhere in the Continental U.S. During COVID-19 Pandemic. #cancerscreening preemptcrc.com https://www.freenome.com/news-resources

The Freenome team is excited to announce the initiation of PREEMPT CRC, a pivotal clinical study for the detection and prevention of colorectal cancer through a multiomics blood test, along with the addition of Gary Reedy, CEO of the American Cancer Society, to the Board of Directors and William Quirk as Chief Financial Officer. Join our team to help us change cancer care through early detection and prevention! #CRCScreening #Earlydetection http://bit.ly/FreenomeCareer https://bit.ly/PREEMPTCRC

Over 20,000 women and their families are welcomed at The Women's Building of San Francisco each year, and every $100 provides four women with free, critical services on issues like domestic violence, safe housing as well as receive tech tutoring, free food, legal services, public benefits and more. Please support The Women's Building of San Francisco and Freenome's efforts by donating and sharing with your friends and family. https://tinyurl.com/yfq8bnfb

We announced promising data for our multiomics blood test to detect early-stage colorectal cancer in a prospective, multi-center clinical study to be presented at ASCO GI on Saturday, January 25th, in San Francisco. Learn more about our study and exciting results: http://bit.ly/ASCOGIPOSTER2020 #GI20 #MultiOmics #CRCScreening

Freenome is hosting a fireside chat this Friday, Jan. 17th with Distinguished Scientist in Residence, Professor Barbara Engelhardt of Princeton University, and special guest Dr. Brendan Bulik-Sullivan, a scientist and life sciences investment partner at Google Ventures to discuss the opportunities and challenges of applying #machinelearning to #biologicaldata. Join us! http://bit.ly/FnFiresideChat